The digital health ecosystem includes digital diagnostics, digital biomarkers, remote patient monitoring tools, wearables and biologic sensors, point of care and clinical workflow enhancement tools and digital therapeutics – clinical interventions delivered directly to individuals via software to treat, manage or prevent a disease or disorder. DIADH will embrace this full spectrum of digital health in the work it supports.

Through this new initiative -- with guidance from alumni and industry leaders, and philanthropic gifts from visionary donors – DIADH helps Dartmouth teams develop and evaluate their digital health novel solutions and harness the resources needed to accelerate the implementation of these solutions to improve people’s lives.

• Expand the reach of CTBH and Dartmouth science to improve people’s lives
• Support interdisciplinary teams to accelerate the real-world implementation of novel, clinically-validated digital health applications and digital therapeutics
• Help Ensure that science-based digital health products reach a sufficient state of maturity to reach a value inflection point
• Give Dartmouth faculty, students, and staff knowledge about the business of digital health and digital therapeutics
• Showcase Dartmouth’s pioneering and wide-reaching research in the science of digital therapeutics
• Grow strategic industry partnerships to commercialize the most potent digital health solutions
• Create a better understanding of the most timely and significant research questions in partnership with industry, payor, regulatory, and other partners

There are many steps that a discovery made in a research setting must go through before it will gain traction with potential partners who can bring it to market.

The Dartmouth Innovation Accelerator for Digital Health features:

• A 2-day bootcamp-style experience to immerse teams in the entrepreneurial process
• Three months of guidance from instructors to continue to develop their project idea
• Support from staff, mentors, and Entrepreneurs in Residence
• Access to competitive intelligence via Informa’s Pharmaprojects and Meddevicetracker
• Access to Palamedes Partners for Market Research Reports
• An opportunity to pitch to and get feedback from the Accelerator’s External Review Panel comprising top investors and executives in digital health
• Meaningful funding awards of up to $50,000 upon completion of the program

Key dates to be announced.

Registration is currently closed. Please check back for future registration dates and details.

Please contact DIADH@dartmouth.edu with any questions.